Deutsche Bank
SNOA icon

Deutsche Bank’s Sonoma Pharmaceuticals SNOA Stock Holding History

Deutsche Bank’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-25
Closed -$2K – 4780
2019
Q4 		$2K Buy
+25
New +$2.49K ﹤0.01% 4845
2018
Q2 		– Sell
-113
Closed -$74K – 5597
2018
Q1 		$74K Sell
113
-27
-19% -$22.2K ﹤0.01% 4626
2017
Q4 		$137K Buy
+140
New +$120K ﹤0.01% 4164
2017
Q3 		– Sell
-8
Closed -$9K – 5061
2017
Q2 		$9K Buy
+8
New +$9.87K ﹤0.01% 4682
2015
Q3 		– Sell
-21
Closed -$26K – 5318
2015
Q2 		$26K Buy
+21
New +$19.7K ﹤0.01% 4837

Other funds holding SNOA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
RE
RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

Deutsche Bank's SNOA Position: Q1 2020 in Review

Deutsche Bank sold out of Sonoma Pharmaceuticals (SNOA) in Q1 2020, closing a stake of 25 shares — an estimated $2K sold.

Deutsche Bank first reported a position in SNOA in Q2 2015 and held it in 5 quarters. The position peaked at $137K in Q4 2017. 14 funds tracked by Wall St. Rank hold SNOA as of Q1 2020.

  • Deutsche Bank reported no remaining Sonoma Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Deutsche Bank sold 25 Sonoma Pharmaceuticals shares in Q1 2020, an estimated $2K.
  • Deutsche Bank first reported a position in Sonoma Pharmaceuticals in Q2 2015 and held it in 5 quarters.
  • Deutsche Bank's Sonoma Pharmaceuticals position peaked at $137K in Q4 2017.
  • 14 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.